Pacira BioSciences, Inc. (PCRX) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $22.59
• Market Cap: $1.01B
• P/E Ratio: 49.91
• EPS: $0.47
• 52-Week High: $27.64
• 52-Week Low: $18.80

Market Sentiment

Pacira BioSciences, Inc. currently has a Neutral sentiment score of 0.01.

About Pacira BioSciences, Inc.

Pacira BioSciences, Inc. (PCRX) is a pioneering biopharmaceutical company headquartered in Parsippany, New Jersey, dedicated to transforming pain management through innovative non-opioid therapies and regenerative health solutions. By focusing on advanced pain management alternatives, Pacira addresses the critical need for effective solutions that reduce opioid reliance, thereby enhancing patient outcomes and supporting healthcare professionals' practices. With a robust pipeline and a strong ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Pacira BioSciences, Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PCRX pay dividends?

Pacira BioSciences, Inc. (PCRX) does not currently pay a regular dividend.

What is PCRX's P/E ratio?

Pacira BioSciences, Inc. has a price-to-earnings (P/E) ratio of 49.91.

What is PCRX's market cap?

Pacira BioSciences, Inc. (PCRX) has a market capitalization of $1.01B with a current stock price of $22.59.